Keyphrases
Lipids
100%
TRP Channels
100%
Oral Cancer Pain
100%
Transient Receptor Potential Vanilloid 1 (TRPV1)
57%
Tumor
42%
Mechanical Allodynia
42%
Nocifensive Behavior
42%
Oral Squamous Cell Carcinoma Cells
42%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
28%
Thermal Hypersensitivity
28%
Thermal Allodynia
28%
Cancer Pain
28%
TRPA1 Antagonists
28%
Oral Cancer
14%
Cellular Mechanisms
14%
Novel Mechanism
14%
Cancer Cells
14%
Head-and-neck
14%
Induced Activation
14%
Behavioral Tests
14%
Nociceptor
14%
Sensory Neurons
14%
Gaps in Knowledge
14%
In Cancer
14%
Saliva
14%
Conditioned Medium
14%
Arachidonic Acid
14%
Hind Paw
14%
Mechanical Hypersensitivity
14%
Linoleic Acid
14%
Nocifensive
14%
Lipid Extract
14%
Normal Cell Line
14%
Cell Control
14%
Early Symptoms
14%
Lipid-mediated
14%
Large Gap
14%
Hydroxyeicosatetraenoic Acid
14%
Hydroxyoctadecadienoic Acid
14%
Oral Cancer Patients
14%
TRPV1 Antagonist
14%
HC-030031
14%
Keratinocyte Cell Line
14%
Human Oral Keratinocytes
14%
Medicine and Dentistry
Oral Cancer
100%
Cancer Pain
100%
Transient Receptor Potential Channel
100%
Neoplasm
60%
Hypersensitivity
60%
Mechanical Allodynia
60%
Mouth Squamous Cell Carcinoma
40%
Cell Line
40%
TRPV1
40%
Oral Squamous Cell Carcinoma Cell Line
40%
Thermal Allodynia
40%
Cancer Cell
20%
Receptor
20%
Nociceptor
20%
Cellular Mechanism
20%
Neck
20%
Gene Linkage
20%
Arachidonic Acid
20%
Linoleic Acid
20%
Vanilloid Receptor 1 Antagonist
20%
Hydroxyicosatetraenoic Acid
20%
Lipid
20%
Keratinocyte Cell Line
20%
N (4 Isopropylphenyl) 2 (1,2,3,6 Tetrahydro 1,3 Dimethyl 2,6 Dioxo 7h Purin 7 Yl)acetamide
20%
N [4 [6 [4 (Trifluoromethyl)phenyl] 4 Pyrimidinyloxy]benzothiazol 2 Yl]acetamide
20%
Pharmacology, Toxicology and Pharmaceutical Science
Cancer Pain
100%
Mouth Cancer
100%
Transient Receptor Potential Channel
100%
Mouth Squamous Cell Carcinoma
80%
Neoplasm
60%
Erethism
60%
Mechanical Allodynia
60%
Thermal Allodynia
40%
Malignant Neoplasm
20%
Receptor
20%
Normal Human
20%
Arachidonic Acid
20%
Linoleic Acid
20%
Hydroxyicosatetraenoic Acid
20%
Lipid
20%
Vanilloid Receptor 1 Antagonist
20%
N (4 Isopropylphenyl) 2 (1,2,3,6 Tetrahydro 1,3 Dimethyl 2,6 Dioxo 7h Purin 7 Yl)acetamide
20%
N [4 [6 [4 (Trifluoromethyl)phenyl] 4 Pyrimidinyloxy]benzothiazol 2 Yl]acetamide
20%